Trial intelligence / Profile preview

Effect of Acute Exercise on SARS-CoV-2 T-cells

NCT05019456Active, not recruiting

Sponsor
University of Arizona
Start
Mar 2021
Primary completion
Dec 2025
Countries
1
01

Overview

Open-label, single-arm trial, sponsored by University of Arizona. Primary endpoints: Interferon-gamma concentration, Interferon-gamma spot forming cells and 3 more. Started Mar 2021; status: active, not recruiting.

Beyond the preview

Go deeper on NCT05019456.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05019456.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call